NUTRACEUTICAL INTERNATIONAL CORP
CIK:0001050007|SEC Filings
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
| Income Statement [Abstract] | ||||
| Net sales | $ 64,993 | $ 60,836 | $ 182,827 | $ 176,287 |
| Cost of sales | 31,600 | 29,416 | 89,419 | 86,430 |
| Gross profit | 33,393 | 31,420 | 93,408 | 89,857 |
| Operating expenses | ||||
| Selling, general and administrative | 25,261 | 21,895 | 69,317 | 64,016 |
| Business Acquisition, Transaction Costs | 2,556 | 0 | 2,766 | 0 |
| Amortization of intangible assets | 1,357 | 988 | 3,183 | 2,968 |
| Income from operations | 4,219 | 8,537 | 18,142 | 22,873 |
| Interest and other expense, net | 380 | 326 | 1,022 | 922 |
| Income before provision for income taxes | 3,839 | 8,211 | 17,120 | 21,951 |
| Provision for income taxes | 1,982 | 2,182 | 6,600 | 7,063 |
| Net income | 1,857 | 6,029 | 10,520 | 14,888 |
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustment, net of tax | 82 | (118) | (57) | (135) |
| Comprehensive income | $ 1,939 | $ 5,911 | $ 10,463 | $ 14,753 |
| Net income per common share | ||||
| Basic (in dollars per share) | $ 0.20 | $ 0.65 | $ 1.14 | $ 1.59 |
| Diluted (in dollars per share) | $ 0.20 | $ 0.65 | $ 1.14 | $ 1.59 |
| Weighted average common shares outstanding | ||||
| Basic (in shares) | 9,246,902 | 9,310,097 | 9,235,063 | 9,390,765 |
| Dilutive effect of equity awards (in shares) | 10,648 | 0 | 3,549 | 0 |
| Diluted (in shares) | 9,257,550 | 9,310,097 | 9,238,612 | 9,390,765 |
| Cash dividend declared per common share (in dollars per share) | $ 0 | $ 0 | $ 0.25 | $ 0 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands |
Jun. 30, 2017 |
Sep. 30, 2016 |
[1] | ||
|---|---|---|---|---|---|
| Current assets: | |||||
| Cash | $ 4,183 | $ 6,803 | |||
| Accounts receivable, net | 20,993 | 17,680 | |||
| Inventories | 68,558 | 63,923 | |||
| Prepaid expenses and other current assets | 6,085 | 4,217 | |||
| Deferred income taxes | 1,250 | 1,243 | |||
| Total current assets | 101,069 | 93,866 | |||
| Property, plant and equipment, net | 82,184 | 83,048 | |||
| Goodwill | 38,582 | 30,925 | |||
| Intangible assets, net | 28,262 | 22,277 | |||
| Deferred income taxes | 5,037 | 4,310 | |||
| Other non-current assets | 1,324 | 1,429 | |||
| Total assets | 256,458 | 235,855 | |||
| Current liabilities: | |||||
| Accounts payable | 16,372 | 12,696 | |||
| Accrued expenses | 6,599 | 7,469 | |||
| Total current liabilities | 22,971 | 20,165 | |||
| Long-term debt | 50,500 | 43,500 | |||
| Other non-current liabilities | 750 | 200 | |||
| Total liabilities | 74,221 | 63,865 | |||
| Stockholders' equity: | |||||
| Common stock | 93 | 92 | |||
| Additional paid-in capital | 2,146 | 52 | |||
| Retained earnings | 180,485 | 172,276 | |||
| Accumulated other comprehensive loss | (487) | (430) | |||
| Total stockholders' equity | 182,237 | 171,990 | |||
| Total liabilities and stockholders' equity | $ 256,458 | $ 235,855 | |||
| |||||